Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women

Anne Zeleniuch-Jacquotte, Peter F. Bruning, Johannes M G Bonfrer, Karen L. Koenig, Roy E. Shore, Mimi Kim, Bernard S. Pasternack, Paolo Toniolo

Research output: Contribution to journalArticle

109 Citations (Scopus)

Abstract

The authors examined the relation between postmenopausal serum levels of testosterone and dehydroepiandrosterone sulfate (DHEAS) and subsequent risk of breast cancer in a case-control study nested within the New York University Women's Health Study cohort. A specific objective of their analysis was to examine whether androgens had an effect on breast cancer risk independent of their effect on the biologic availability of estrogen. A total of 130 cases of breast cancer were diagnosed prior to 1991 in a cohort of 7,054 postmenopausal women who had donated blood and completed questionnaires at a breast cancer screening clinic in New York City between 1985 and 1991. For each case, two controls were selected, matching the case on age at blood donation and length of storage of serum specimens. Biochemical analyses were performed on sere that had been stored at -80°C since sampling. The present report includes a subset of 85 matched sets, for whom at least 6 months had elapsed between blood donation and diagnosis of the case. In univariate analysis, testosterone was positively associated with breast cancer risk (odds ratio (OR) for the highest quartile = 2.7, 95% confidence interval (CI) 1.1-6.8, p < 0.05, test for trend). However, after including % estradiol bound to sex hormone-binding globulin (SHBG) and total estradiol in the statistical model, the odds ratios associated with higher levels of testosterone were considerably reduced, and there was no longer a significant trend (OR for the highest quartile = 1.2, 95% CI 0.4-3.5). Conversely, breast cancer risk remained positively associated with total estradiol levels (OR for the highest quartile = 2.9, 95% CI 1.0-8.3) and negatively associated with % estradiol bound to SHBG (OR for the highest quartile = 0.05, 95% CI 0.01-0.19) after adjustment for serum testosterone levels. These results are consistent with the hypothesis that testosterone has an indirect effect on breast cancer risk, via its influence on the amount of bioavailable estrogen. No evidence was found of an association between DHEAS and risk of breast cancer in postmenopausal women.

Original languageEnglish (US)
Pages (from-to)1030-1038
Number of pages9
JournalAmerican Journal of Epidemiology
Volume145
Issue number11
StatePublished - Jun 1 1997
Externally publishedYes

Fingerprint

Dehydroepiandrosterone Sulfate
Testosterone
Breast Neoplasms
Odds Ratio
Serum
Estradiol
Confidence Intervals
Sex Hormone-Binding Globulin
Blood Donors
Estrogens
Statistical Models
Women's Health
Early Detection of Cancer
Biological Availability
Androgens
Case-Control Studies
Cohort Studies

Keywords

  • androgens
  • breast neoplasms
  • DHEAS
  • estrogens
  • testosterone

ASJC Scopus subject areas

  • Epidemiology

Cite this

Zeleniuch-Jacquotte, A., Bruning, P. F., Bonfrer, J. M. G., Koenig, K. L., Shore, R. E., Kim, M., ... Toniolo, P. (1997). Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. American Journal of Epidemiology, 145(11), 1030-1038.

Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. / Zeleniuch-Jacquotte, Anne; Bruning, Peter F.; Bonfrer, Johannes M G; Koenig, Karen L.; Shore, Roy E.; Kim, Mimi; Pasternack, Bernard S.; Toniolo, Paolo.

In: American Journal of Epidemiology, Vol. 145, No. 11, 01.06.1997, p. 1030-1038.

Research output: Contribution to journalArticle

Zeleniuch-Jacquotte, A, Bruning, PF, Bonfrer, JMG, Koenig, KL, Shore, RE, Kim, M, Pasternack, BS & Toniolo, P 1997, 'Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women', American Journal of Epidemiology, vol. 145, no. 11, pp. 1030-1038.
Zeleniuch-Jacquotte, Anne ; Bruning, Peter F. ; Bonfrer, Johannes M G ; Koenig, Karen L. ; Shore, Roy E. ; Kim, Mimi ; Pasternack, Bernard S. ; Toniolo, Paolo. / Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women. In: American Journal of Epidemiology. 1997 ; Vol. 145, No. 11. pp. 1030-1038.
@article{fb8e58adc50043e48b6001637dbbbd33,
title = "Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women",
abstract = "The authors examined the relation between postmenopausal serum levels of testosterone and dehydroepiandrosterone sulfate (DHEAS) and subsequent risk of breast cancer in a case-control study nested within the New York University Women's Health Study cohort. A specific objective of their analysis was to examine whether androgens had an effect on breast cancer risk independent of their effect on the biologic availability of estrogen. A total of 130 cases of breast cancer were diagnosed prior to 1991 in a cohort of 7,054 postmenopausal women who had donated blood and completed questionnaires at a breast cancer screening clinic in New York City between 1985 and 1991. For each case, two controls were selected, matching the case on age at blood donation and length of storage of serum specimens. Biochemical analyses were performed on sere that had been stored at -80°C since sampling. The present report includes a subset of 85 matched sets, for whom at least 6 months had elapsed between blood donation and diagnosis of the case. In univariate analysis, testosterone was positively associated with breast cancer risk (odds ratio (OR) for the highest quartile = 2.7, 95{\%} confidence interval (CI) 1.1-6.8, p < 0.05, test for trend). However, after including {\%} estradiol bound to sex hormone-binding globulin (SHBG) and total estradiol in the statistical model, the odds ratios associated with higher levels of testosterone were considerably reduced, and there was no longer a significant trend (OR for the highest quartile = 1.2, 95{\%} CI 0.4-3.5). Conversely, breast cancer risk remained positively associated with total estradiol levels (OR for the highest quartile = 2.9, 95{\%} CI 1.0-8.3) and negatively associated with {\%} estradiol bound to SHBG (OR for the highest quartile = 0.05, 95{\%} CI 0.01-0.19) after adjustment for serum testosterone levels. These results are consistent with the hypothesis that testosterone has an indirect effect on breast cancer risk, via its influence on the amount of bioavailable estrogen. No evidence was found of an association between DHEAS and risk of breast cancer in postmenopausal women.",
keywords = "androgens, breast neoplasms, DHEAS, estrogens, testosterone",
author = "Anne Zeleniuch-Jacquotte and Bruning, {Peter F.} and Bonfrer, {Johannes M G} and Koenig, {Karen L.} and Shore, {Roy E.} and Mimi Kim and Pasternack, {Bernard S.} and Paolo Toniolo",
year = "1997",
month = "6",
day = "1",
language = "English (US)",
volume = "145",
pages = "1030--1038",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "11",

}

TY - JOUR

T1 - Relation of serum levels of testosterone and dehydroepiandrosterone sulfate to risk of breast cancer in postmenopausal women

AU - Zeleniuch-Jacquotte, Anne

AU - Bruning, Peter F.

AU - Bonfrer, Johannes M G

AU - Koenig, Karen L.

AU - Shore, Roy E.

AU - Kim, Mimi

AU - Pasternack, Bernard S.

AU - Toniolo, Paolo

PY - 1997/6/1

Y1 - 1997/6/1

N2 - The authors examined the relation between postmenopausal serum levels of testosterone and dehydroepiandrosterone sulfate (DHEAS) and subsequent risk of breast cancer in a case-control study nested within the New York University Women's Health Study cohort. A specific objective of their analysis was to examine whether androgens had an effect on breast cancer risk independent of their effect on the biologic availability of estrogen. A total of 130 cases of breast cancer were diagnosed prior to 1991 in a cohort of 7,054 postmenopausal women who had donated blood and completed questionnaires at a breast cancer screening clinic in New York City between 1985 and 1991. For each case, two controls were selected, matching the case on age at blood donation and length of storage of serum specimens. Biochemical analyses were performed on sere that had been stored at -80°C since sampling. The present report includes a subset of 85 matched sets, for whom at least 6 months had elapsed between blood donation and diagnosis of the case. In univariate analysis, testosterone was positively associated with breast cancer risk (odds ratio (OR) for the highest quartile = 2.7, 95% confidence interval (CI) 1.1-6.8, p < 0.05, test for trend). However, after including % estradiol bound to sex hormone-binding globulin (SHBG) and total estradiol in the statistical model, the odds ratios associated with higher levels of testosterone were considerably reduced, and there was no longer a significant trend (OR for the highest quartile = 1.2, 95% CI 0.4-3.5). Conversely, breast cancer risk remained positively associated with total estradiol levels (OR for the highest quartile = 2.9, 95% CI 1.0-8.3) and negatively associated with % estradiol bound to SHBG (OR for the highest quartile = 0.05, 95% CI 0.01-0.19) after adjustment for serum testosterone levels. These results are consistent with the hypothesis that testosterone has an indirect effect on breast cancer risk, via its influence on the amount of bioavailable estrogen. No evidence was found of an association between DHEAS and risk of breast cancer in postmenopausal women.

AB - The authors examined the relation between postmenopausal serum levels of testosterone and dehydroepiandrosterone sulfate (DHEAS) and subsequent risk of breast cancer in a case-control study nested within the New York University Women's Health Study cohort. A specific objective of their analysis was to examine whether androgens had an effect on breast cancer risk independent of their effect on the biologic availability of estrogen. A total of 130 cases of breast cancer were diagnosed prior to 1991 in a cohort of 7,054 postmenopausal women who had donated blood and completed questionnaires at a breast cancer screening clinic in New York City between 1985 and 1991. For each case, two controls were selected, matching the case on age at blood donation and length of storage of serum specimens. Biochemical analyses were performed on sere that had been stored at -80°C since sampling. The present report includes a subset of 85 matched sets, for whom at least 6 months had elapsed between blood donation and diagnosis of the case. In univariate analysis, testosterone was positively associated with breast cancer risk (odds ratio (OR) for the highest quartile = 2.7, 95% confidence interval (CI) 1.1-6.8, p < 0.05, test for trend). However, after including % estradiol bound to sex hormone-binding globulin (SHBG) and total estradiol in the statistical model, the odds ratios associated with higher levels of testosterone were considerably reduced, and there was no longer a significant trend (OR for the highest quartile = 1.2, 95% CI 0.4-3.5). Conversely, breast cancer risk remained positively associated with total estradiol levels (OR for the highest quartile = 2.9, 95% CI 1.0-8.3) and negatively associated with % estradiol bound to SHBG (OR for the highest quartile = 0.05, 95% CI 0.01-0.19) after adjustment for serum testosterone levels. These results are consistent with the hypothesis that testosterone has an indirect effect on breast cancer risk, via its influence on the amount of bioavailable estrogen. No evidence was found of an association between DHEAS and risk of breast cancer in postmenopausal women.

KW - androgens

KW - breast neoplasms

KW - DHEAS

KW - estrogens

KW - testosterone

UR - http://www.scopus.com/inward/record.url?scp=0030912932&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030912932&partnerID=8YFLogxK

M3 - Article

VL - 145

SP - 1030

EP - 1038

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 11

ER -